Benzethonium

Benzethonium

SCHEMBL122985

CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 1.00
HIF1A Q16665 4/20 1.00
LMNA P02545 3/20 1.00
TSHR P16473 3/20 1.00
TDP1 Q9NUW8 3/20 1.00
MEN1 O00255 3/20 1.00
APAF1 O14727 3/20 1.00
USP2 O75604 3/20 1.00
ALDH1A1 P00352 3/20 1.00
TP53 P04637 3/20 1.00
MAPT P10636 3/20 1.00
RAD52 P43351 3/20 1.00
KMT2A Q03164 3/20 1.00
CYP3A4 P08684 3/20 1.00
ERBB2 P04626 2/20 1.00
FYN P06241 2/20 1.00
CHRM2 P08172 2/20 1.00
CHRM4 P08173 2/20 1.00
CHRM5 P08912 2/20 1.00
ADRA2A P08913 2/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzethonium SCHEMBL1282115 0.99 SMN1; SMN2 (0.98) SMN1; SMN2HIF1ALMNATSHRTDP1
Benzethonium SCHEMBL21713 0.99 SMN1; SMN2 (1.00) SMN1; SMN2HIF1ALMNATSHRTDP1
Benzethonium SCHEMBL5549294 0.99 SMN1; SMN2 (0.98) SMN1; SMN2HIF1ALMNATSHRTDP1
Benzethonium SCHEMBL27797280 0.99 SMN1; SMN2 (1.00) SMN1; SMN2HIF1ALMNATSHRTDP1
Benzethonium SCHEMBL1672928 0.99 SMN1; SMN2 (0.98) SMN1; SMN2HIF1ALMNATSHRTDP1
Benzethonium SCHEMBL4418328 0.99 SMN1; SMN2 (0.98) SMN1; SMN2HIF1ALMNATSHRTDP1
Benzethonium SCHEMBL927612 0.99 SMN1; SMN2 (0.98) SMN1; SMN2HIF1ALMNATSHRTDP1
Benzethonium SCHEMBL1951703 0.99 SMN1; SMN2 (0.98) SMN1; SMN2HIF1ALMNATSHRTDP1
Benzethonium SCHEMBL22711570 0.99 SMN1; SMN2 (0.98) SMN1; SMN2HIF1ALMNATSHRTDP1
Benzethonium SCHEMBL976363 0.98 SMN1; SMN2 (0.98) SMN1; SMN2HIF1ALMNATSHRTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 5638 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3569608-B1 OLIGOSACCHARIDE COMPOUND FOR INHIBITING ENDOGENOUS COAGULATION FACTOR X-ENZYME COMPLEX, AND PREPARATION METHOD THEREFOR AND USES THEREOF JIUZHITANG CO LTD (CN) 2026-05-20 EP claimed
EP-3883534-B1 OILY FACIAL CARE PREPARATION BEIERSDORF AG (DE) 2026-05-06 EP claimed
EP-4712944-A1 TOPICAL PHARMACEUTICAL SKIN COMPOSITION FOR THE DELIVERY OF NITRIC OXIDE IN COMBINATION WITH OTHER TOPICAL DERMATOLOGIC AGENTS Noxy Health Products, Inc. (US) 2026-03-25 EP claimed
US-12551596-B2 Delivery systems for administration of cationic biological actives ALLVIVO VASCULAR, INC. (US) 2026-02-17 US claimed
US-20260043148-A1 CLEANING COMPOSITION WITH MOLYBDENUM ETCHING INHIBITOR ENTEGRIS INC (US) 2026-02-12 US claimed
US-20250345461-A1 METHOD FOR REPAIRING HAIR CYCLE-RELATED GENES AND METHOD FOR TREATING HAIR CYCLE-RELATED DISEASES USING MIR-520D-5P LIVIUS PTE LTD (SG) 2025-11-13 US claimed
EP-4642858-A1 COATING COMPOSITION FOR COVERING A SURFACE AREA COMPRISING TUNGSTEN ON A SEMICONDUCTOR DEVICE DURING AN ATOMIC LAYER DEPOSITION PROCESS BASF SE (DE) 2025-11-05 EP claimed
US-12390487-B2 Antiseptic skin prep composition SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) 2025-08-19 US claimed
US-12378439-B2 Compositions for tungsten etching inhibition BASF SE (DE) 2025-08-05 US claimed
EP-4588478-A1 USE OF BENCYCLOQUIDIUM BROMIDE, ISOMER THEREOF AND DERIVATIVE THEREOF IN PREPARATION OF OPHTHALMIC FORMULATION Beijing Yingu Medicine SCI Techno Co., Ltd. (CN) 2025-07-23 EP claimed
EP-0141628-A1 Antimicrobial latex composition shaped article produced therefrom, and method of manufacturing a shaped article UNITIKA LTD. (JP) 1985-05-15 EP claimed
EP-0044228-B1 HEPARINE ESTERS FOR USE IN THE MANUFACTURE OF MEDICINES, AND PROCESSES FOR THEIR PREPARATION PHARMUKA LABORATOIRES (FR) 1985-02-13 EP claimed
EP-0026539-B1 Oral compositions with stabilized tin salts Gaba International AG (CH) 1985-01-02 EP claimed
US-4440926-A Heparin esters and processes for their preparation PHARMINDUSTRIE (FR) 1984-04-03 US claimed
EP-0025202-B1 OPHTHALMIC SOLUTION FOR INTRAOCULAR PRESSURE ADJUSTMENT Kaken Pharmaceutical Co., Ltd. (JP) 1983-07-13 EP claimed
EP-0044228-A2 Heparine esters for use in the manufacture of medicines, and processes for their preparation PHARMUKA LABORATOIRES (FR) 1982-01-20 EP claimed
US-4169764-A ADSORPTION, ELUTION AJINOMOTO CO., INC. (JP) 1979-10-02 US claimed
US-4125628-A FORMALDEHYDE, QUATERNARY AMMONIUM SALT VINELAND LABORATORIES, INC. (US) 1978-11-14 US claimed
US-4064232-A Process for isolating the immunogenic components of influenza viruses SANDOZ LTD. (CH) 1977-12-20 US claimed
US-3956480-A DENTIFRICES, CATIONIC GERMICIDE, ANIONIC POLYMERS COLGATE-PALMOLIVE COMPANY (US) 1976-05-11 US claimed